Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression
Vincenzo Quagliariello(Cancer Institute (WIA)), Nicola Maurea(Cancer Institute (WIA)), R. Taibi, Simona Buccolo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano Berretta(University of Messina), Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Monica Montopoli(University of Padua), Ernesta Cavalcanti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 45
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Basic principles of biobanking: from biological samples to precision medicine for patients
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021|223
Metabolic Plasticity in Chemotherapy Resistance
|Frontiers in Oncology|2020|175